620 related articles for article (PubMed ID: 16982791)
1. Rapid emergence of resistance to linezolid during linezolid therapy of an Enterococcus faecium infection.
Seedat J; Zick G; Klare I; Konstabel C; Weiler N; Sahly H
Antimicrob Agents Chemother; 2006 Dec; 50(12):4217-9. PubMed ID: 16982791
[TBL] [Abstract][Full Text] [Related]
2. Emerging linezolid-resistant Enterococcus faecalis and Enterococcus faecium isolated from two Austrian patients in the same intensive care unit.
Johnson AP; Tysall L; Stockdale MV; Woodford N; Kaufmann ME; Warner M; Livermore DM; Asboth F; Allerberger FJ
Eur J Clin Microbiol Infect Dis; 2002 Oct; 21(10):751-4. PubMed ID: 12415476
[TBL] [Abstract][Full Text] [Related]
3. Varying linezolid susceptibility of vancomycin-resistant Enterococcus faecium isolates during therapy: a case report.
Swoboda S; Fritz S; Martignoni ME; Feldhues RA; Hoppe-Tichy T; Buchler MW; Geiss HK
J Antimicrob Chemother; 2005 Oct; 56(4):787-9. PubMed ID: 16143710
[TBL] [Abstract][Full Text] [Related]
4. Emergence of linezolid resistance in the vancomycin-resistant Enterococcus faecium multilocus sequence typing C1 epidemic lineage.
Bonora MG; Solbiati M; Stepan E; Zorzi A; Luzzani A; Catania MR; Fontana R
J Clin Microbiol; 2006 Mar; 44(3):1153-5. PubMed ID: 16517918
[TBL] [Abstract][Full Text] [Related]
5. Successful treatment of persistent vancomycin-resistant Enterococcus faecium bacteremia with linezolid and gentamicin.
Noskin GA; Siddiqui F; Stosor V; Kruzynski J; Peterson LR
Clin Infect Dis; 1999 Mar; 28(3):689-90. PubMed ID: 10194104
[No Abstract] [Full Text] [Related]
6. Nosocomial spread of linezolid-resistant, vancomycin-resistant Enterococcus faecium.
Herrero IA; Issa NC; Patel R
N Engl J Med; 2002 Mar; 346(11):867-9. PubMed ID: 11893808
[No Abstract] [Full Text] [Related]
7. Risk factors associated with the development of infection with linezolid- and vancomycin-resistant Enterococcus faecium.
Pai MP; Rodvold KA; Schreckenberger PC; Gonzales RD; Petrolatti JM; Quinn JP
Clin Infect Dis; 2002 Nov; 35(10):1269-72. PubMed ID: 12410489
[TBL] [Abstract][Full Text] [Related]
8. Emergence of linezolid-resistant Enterococcus faecium during treatment of enterococcal infections.
Bassetti M; Farrel PA; Callan DA; Topal JE; Dembry LM
Int J Antimicrob Agents; 2003 Jun; 21(6):593-4. PubMed ID: 12791477
[No Abstract] [Full Text] [Related]
9. First report of a linezolid- and vancomycin-resistant Enterococcus faecium strain in Korea.
Bae HG; Sung H; Kim MN; Lee EJ; Koo Lee S
Scand J Infect Dis; 2006; 38(5):383-6. PubMed ID: 16709544
[TBL] [Abstract][Full Text] [Related]
10. Linezolid treatment for osteomyelitis due to vancomycin-resistant Enterococcus faecium.
Till M; Wixson RL; Pertel PE
Clin Infect Dis; 2002 May; 34(10):1412-4. PubMed ID: 11981739
[TBL] [Abstract][Full Text] [Related]
11. In vitro activities of tigecycline, daptomycin, linezolid and quinupristin/dalfopristin against glycopeptide-resistant Enterococcus faecium.
Abb J
Int J Antimicrob Agents; 2007 Mar; 29(3):358-60. PubMed ID: 17229553
[No Abstract] [Full Text] [Related]
12. Linezolid-resistant Enterococcus faecium and Enterococcus faecalis isolated from a septic patient: report of first isolates in Germany.
Halle E; Padberg J; Rosseau S; Klare I; Werner G; Witte W
Infection; 2004 Jun; 32(3):182-3. PubMed ID: 15188081
[TBL] [Abstract][Full Text] [Related]
13. First linezolid- and vancomycin-resistant Enterococcus faecium strain in Taiwan.
Liao CH; Tseng SP; Fang CT; Teng LJ; Hsueh PR
J Antimicrob Chemother; 2005 Apr; 55(4):598-9. PubMed ID: 15728149
[No Abstract] [Full Text] [Related]
14. In vitro activity of fosfomycin tromethamine and linezolid against vancomycin-resistant Enterococcus faecium isolates.
Cilli F; Pullukcu H; Aydemir S; Sipahi OR; Tasbakan M; Turhan A; Ulusoy S
Int J Antimicrob Agents; 2008 Mar; 31(3):297-8. PubMed ID: 18180144
[No Abstract] [Full Text] [Related]
15. Intensive care unit dissemination of multiple clones of linezolid-resistant Enterococcus faecalis and Enterococcus faecium.
Ntokou E; Stathopoulos C; Kristo I; Dimitroulia E; Labrou M; Vasdeki A; Makris D; Zakynthinos E; Tsakris A; Pournaras S
J Antimicrob Chemother; 2012 Aug; 67(8):1819-23. PubMed ID: 22532462
[TBL] [Abstract][Full Text] [Related]
16. The clinical impact of linezolid susceptibility reporting in patients with vancomycin-resistant enterococci.
Scheetz MH; Qi C; Noskin GA; Warren JR; Postelnick MJ; Malczynski M; Huang J; Zembower TR
Diagn Microbiol Infect Dis; 2006 Dec; 56(4):407-13. PubMed ID: 16930924
[TBL] [Abstract][Full Text] [Related]
17. Successful treatment of vancomycin-resistant Enterococcus endocarditis with oral linezolid.
Babcock HM; Ritchie DJ; Christiansen E; Starlin R; Little R; Stanley S
Clin Infect Dis; 2001 May; 32(9):1373-5. PubMed ID: 11303275
[TBL] [Abstract][Full Text] [Related]
18. Linezolid-resistant, vancomycin-resistant Enterococcus faecium infection in patients without prior exposure to linezolid.
Rahim S; Pillai SK; Gold HS; Venkataraman L; Inglima K; Press RA
Clin Infect Dis; 2003 Jun; 36(11):E146-8. PubMed ID: 12766857
[TBL] [Abstract][Full Text] [Related]
19. Infections due to vancomycin-resistant Enterococcus faecium resistant to linezolid.
Gonzales RD; Schreckenberger PC; Graham MB; Kelkar S; DenBesten K; Quinn JP
Lancet; 2001 Apr; 357(9263):1179. PubMed ID: 11323048
[TBL] [Abstract][Full Text] [Related]
20. Vancomycin-resistant Enterococcus faecium meningitis successfully managed with linezolid: case report and review of the literature.
Zeana C; Kubin CJ; Della-Latta P; Hammer SM
Clin Infect Dis; 2001 Aug; 33(4):477-82. PubMed ID: 11462183
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
